Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is the most common defect in fatty acid oxidation. The disease is inherited in an autosomal recessive fashion (carrier frequency around 1 in 70) and probably affects as many as 1 in 10 000 new-borns. Affected children usually present within the two first years of life with recurrent episodes of hypoketotic hypoglycaemia and lethargy leading to death in ∼25% of the cases. One mutation (c985A→G) accounts for ∼90% of the carrier chromosomes. We developed a preimplantation genetic diagnosis (PGD) strategy for MCAD for a couple who had already lost two affected children. When tested on heterozygous lymphoblasts, the amplification efficiency was 67 out of 71 (94%) and the allele dropout rate was 0 out of 67. The patient became pregnant after one PGD cycle during which two embryos were replaced. The twin pregnancy was checked by chorionic villus sampling (CVS) and was shown to be unaffected. The twins have been born and are healthy.
Introduction
chromosomes, was an A→G transition at cDNA position 985, resulting in a change of amino acid residue 329 from lysine Medium-chain acyl-CoA dehydrogenase (MCAD, MIM to glutamic acid (K329E). Until recently, 21 other and rarer #201450) deficiency is one of the most common recessivelymutations have been described (Andresen et al., 1997) . In inherited defects in fatty acid oxidation, which takes place in the first reports on the c985A→G mutation, a quick method the mitochondria. The incidence of the disease may be as high to determine the presence of the mutation was described as 1 in 10 000 births in Northern Europe, with an estimated (Matsubara et al., 1990; Gregersen et al., 1991) : using polycarrier frequency of the most frequent mutation (c985A→G) merase chain reaction (PCR) with a primer mismatched at the of between 1 in 50 (Finland) and 1 in 240 (Czech Republic) site of the mutation, a NcoI restriction site was introduced in (Tanaka et al., 1997) . Affected children usually present within the mutated sequence. We have used an adaptation of this the first 2 years of life during periods of fasting (e.g. during strategy for the development of a PCR test at the singleconcurrent viral gastro-intestinal infection) with recurrent cell level. This test was used for preimplantation genetic episodes of hypoglycaemia associated with very low or no diagnosis (PGD) in a couple of which both partners carried ketone bodies in their urine, reflecting their inability to the commonest c985A→G mutation and who had already lost metabolize medium-chain fatty acids. They often present in a two affected children. coma or with an altered level of consciousness and~25% of affected children die during this initial presentation. Long-
Materials and methods
term follow-up of MCAD deficiency patients has shown significant morbidity, ranging from low achievement at school
Patient description
to severe handicap (epilepsy, hemiplegia and marked delay),
Patients were a healthy, non-consanguineous couple. The wife was amongst survivors of the initial episode (Wilcken et al., 1994) . aged 31 and the husband 32 years at the time of treatment. The Therapeutic measures, e.g. appropriate diet (frequent feeding), couple had lost two children from MCAD at 8 and 9 months of age presenting as sudden infant death syndrome (SIDS) after an episode vitamin and carnitine supplements can avoid the occurrence of gastro-intestinal problems. The diagnosis of MCAD deficiency of these life-threatening episodes.
was made after the second child had died and the c985A→G mutation
The enzyme deficiency responsible for the disease was was found in peripheral blood DNA of both parents (heterozygotes) characterized in 1983 by three groups (Divry et al., 1983;  and the affected child (homozygote). Rhead et al., 1983; Stanley et al., 1983) and the gene was cloned in 1987 (Kelly et al., 1987) . Other authors (Matsubara Sampling of single lymphoblasts Gregersen et al., 1991) were able to show Lymphocytes from the mother were transformed with EpsteinBarr virus and cultured as described earlier (Ventura et al., 1988) .
that the commonest mutation, found in~90% of the carrier Lymphoblast colonies were collected and single lymphoblasts were AAATGGCCATG-3Ј and MCADK2 (reverse primer, labelled with Cy5): 5Ј-CTGTATTAAATCCATTGCCTC-3Ј. The bold C in the put in 0.2 ml PCR tubes containing 2.5 µl alkaline lysis buffer (ALB; 200 mM NaOH, 50 mM dithiothreitol) as described previously forward primer is the mismatched nucleotide which introduces a restriction site in the mutated allele. As the point mutation is (Sermon et al., 1998b) . Per two lymphoblasts collected, one tube containing an aliquot from the last washing droplet in ALB served immediately downstream of the forward primer, the mutant template will direct the insertion of G, rather than A, thus producing an NcoI as a blank. Samples were kept at -80°C until further processing. restriction site (CCATGG). Therefore, a wild-type allele will remain Sampling of single blastomeres from research embryos uncut by NcoI, while a mutated allele will yield a fluorescentlylabelled 170 bp fragment and an unlabelled 16 bp fragment. Embryos from our intracytoplasmic sperm injection (ICSI) programme A reaction mix containing 0.4 µmol/l of each primer, 200 µmol/l which were unsuitable for transfer because they contained Ͼ50% dNTP, 1ϫ Expand High Fidelity Buffer (Roche, Brussels, Belgium), fragments and/or irregular blastomeres or were unsuitable for cryo-20 mmol/l Tricine pH 4.95 for a total volume of 25 µl per sample preservation because they contained Ͼ20% fragments were donated was prepared and decontaminated with the restriction enzyme HaeIII by the patients after giving informed consent and with the approval by incubation at 37°C for at least 3 h, after which the restriction of the institutional ethical committee. The zona pellucida was removed enzyme was inactivated by heating at 65°C for at least 20 min. using acidic Tyrode's solution and single blastomeres were transferred
The single cells were lysed by incubating them at 65°C for 10 min to 0.2 ml PCR tubes containing 2.5 µl ALB as described previously in ALB. Expand High Fidelity polymerase (2.6 IU per sample) was (Sermon et al., 1998a) . For each blastomere, one tube containing an added to the reaction mix, briefly mixed, and 22.5 µl of the reaction aliquot of the last washing droplet served as a blank. Samples were mix was added to each single cell sample. PCR was performed on a kept at -80°C until further processing.
Perkin Elmer PCR System 24000 (Brussels, Belgium) using the ICSI procedure following programme: 2 min denaturation at 95°C followed by 5 cycles of 15 s at 95°C, 30 s at 55°C and 45 s at 72°c followed by The ICSI procedure was performed as previously described (Van an extension for 7 min at 72°C. Steirteghem et al., 1998) . Ovarian stimulation was carried out by a The PCR reaction was followed by a digestion of 1 h at 37°C with desensitising long protocol of the intranasally administered 10 IU NcoI. Six µl of the restriction product was mixed with 6 µl gonadotrophin-releasing hormone agonist, buserelin (Suprefact ® ; loading buffer (5 mg/ml Dextran Blue 2000 in deionized Hoechst, Brussels, Belgium) in association with 150 IU human formamide). Samples were loaded on a 6% sequencing gel (Life menopausal gonadotrophin (HMG) daily (Humegon ® ; Organon, Oss, Technologies, Ghent, Belgium), and run on an ALFExpress Automated The Netherlands; or Pergonal ® ; Serono, Brussels, Belgium). Human Sequencer (Amersham Pharmacia Biotech, Roosendaal, The chorionic gonadotrophin (HCG; 10 000 IU) was administered Netherlands). The results were processed using the fragment analysis (Pregnyl ® , Organon; Profasi, Serono) when at least nine follicles with software provided by the manufacturer (Allele Links, Amersham a diameter of 17 mm were visualized on pelvic ultrasound scan Pharmacia Biotech). (Vandervorst et al., 1998) . Cumulus-oocyte-complexes (n ϭ 14) were retrieved by vaginal ultrasound-guided puncture of the ovarian follicles, 36 h after HCG administration. Eight metaphase II oocytes
Results
were injected with a single sperm. The Petri dishes with the oocytes were incubated in 25 µl droplets of S1 medium (Scandinavian IVF) Single lymphoblasts from the mother until after the biopsy in the morning of day 3 and in S2 medium A total of 71 single lymphoblasts from the carrier mother were showed contamination (2.9%). None of the samples showed Embryo biopsy allele drop-out (ADO) after digestion with the NcoI restricEmbryo biopsy was carried out as previously described (Sermon tion enzyme. et al., 1998a) . Only embryos which had developed to the 7-cell stage and beyond were considered for biopsy, since our policy is to biopsy Single blastomeres from spare embryos two blastomeres from each embryo in order to avoid or reduce the In all, 51 blastomeres from 15 embryos were analysed. Of risk of misdiagnosis (Sermon et al., 1998b) . Briefly, a hole was made these, 47 showed amplification (92.2%), while none of the 51 in the zona pellucida using a stream of acidic Tyrode's solution blanks showed contamination. No restriction was carried out (Scandinavian IVF, Goteborg, Sweden), after which two blastomeres on these samples as it was assumed that the probability that were removed by aspiration. Four embryos which had developed any of the embryos would be a carrier of the c985A→G beyond the 7-cell stage were biopsied and eight blastomeres were obtained. Embryos nos. 1 and 2 were at the 8-cell stage, embryo no. mutation was low. B at transfer) and no. 4 (a homozygous normal, 7-cell, grade B) were transferred in the evening of day three, resulting in
PCR procedure
an ongoing dizygotic twin pregnancy. Embryo no. 3 was
The following newly designed primer set was used, yielding a fragment of 186 bp: MCADK1 (forward primer): 5Ј-TGCTGGCTGcryopreserved in the morning of day 4 (8-cell, grade B). The PGD for MCAD deficiency population. It is estimated that the condition is lethal in 25% of the affected infants if MCAD deficiency is not diagnosed in time, which is why it can be considered as a serious disease, although efficient treatment is now available. MCAD deficiency may also account for a small proportion of sudden infant death syndromes (SIDS), although in MCAD deficiency the infant often shows signs of the disease such as hypoglycaemia, altered level of consciousness and coma, and fatty infiltration can be found in the liver at post-mortem examination. These signs are absent in classic SIDS. Moreover, several retrospective studies and one prospective study were unable to demonstrate a higher incidence of MCAD deficiency in SIDS cases than in the general population (Matsubara et al., 1991; Miller et al., 1992; Arens et al., 1993; Penzien et al., 1994) .
The severity of the disease, as well as its relatively high frequency and the fact that one mutation can be found in 90% of the carrier chromosomes, made it a good candidate for the development of PGD. In this case, the patient couple who requested PGD for MCAD deficiency had already lost two affected children and were both carriers of the c985A→G mutation.
The single-cell PCR assay that we present here shows high amplification efficiency on lymphoblasts (67/71, 94%) as well as on blastomeres (47/51 ϩ 8/8 ϭ 55/59; 93%). The use of fluorescent PCR, followed by analysis on an automated sequencer involves a low level of ADO [no ADO observed in 73 heterozygote cells (lymphoblasts and blastomeres) analysed], as was shown by previous authors (Findlay et al., 1996a,b; Sermon et al., 1998a) . The accuracy of the test was confirmed after a successful PGD cycle, not only by re-analysis (Sermon et al., 1998b) , lanes 6 and 7. This embryo was diagnosed as heterozygous for the our policy has been to biopsy two cells for diagnosis, even mutations. The same results were obtained in embryos nos. 2 and 3 for a test as reliable and efficient as the one described (lanes 8, 9, 10 and 11) . In lanes 12 and 13, a homozygous normal here. Another type of PGD assay for MCAD caused by the embryo (no. 4) was diagnosed. Embryos nos.1 and 4 were transferred to the mother. c985A→G mutation was recently described (Ioulianos et al., 2000) . Here, the mutation is analysed concurrently with a linked polymorphism for which the family is informative, result was confirmed in embryo no. 2, which was unsuitable which increases the chance to detect ADO or contamination for cryopreservation.
if it occurs. Using this type of test, it would probably not be At 12 weeks gestation, chorionic villus sampling (CVS) necessary to biopsy two cells. Hence, we have recently decided was performed and the diagnosis was confirmed (one heterothat, from now on, all newly developed tests would be based zygote and one homozygous normal twin). The twins (a girl on duplex PCR. and a boy) were born vaginally at 37 weeks gestation, weighing Finally, the fact that the two transferred embryos implanted 2740 and 3010 g respectively; both had good Apgar scores. and developed into two normal, healthy babies, suggests, as Both babies were seen at 2.5 months of age and were was already shown extensively on research embryos (Hardy developing normally (weight between 25th and 50th percentile et al., 1990 ) that biopsy of two blastomeres at the 7-cell stage for both children, height third percentile for both children, or beyond, which we consider essential for accurate diagnosis, head circumference between 25th and 50th percentile for both does not compromise further development of the embryos. children), except that the girl had a congenital hip luxation for Analysis of our other PGD cycles in which two blastomeres which she had to wear double diapers.
were biopsied per embryo confirms this observation on a larger scale (Van de Velde et al., 2000) .
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